Skip to main content
. 2012 Apr;33(4):603–608. doi: 10.3174/ajnr.A3065

Patients who presented with ipsilateral IPH after treatment with the PED

No. Sex/Age(yr) Co-Morbidities Aneurysm Type/Location Sizea (Largest Diameter, mm) Previous Treatment No. of PED DAT Regimen Time to Bleed (days) Hematoma Sizeb (mm) Outcome (mRS)
1 M/53 Smoker (40 pack-years) Fusiform/R MCA 21 Clipped 1 ASA, 325 mg; clopidogrel, 75 mg 1 49 × 21 0
Started 5 days before
2 F/49 Smoker (68 pack-years) Saccular/L supraclinoid ICA 5 None 1 ASA, 325 mg; clopidogrel, 75 mg 2 36 × 23 2
Asthma Started 5 days before
3 F/67 HTN Saccular/R supraclinoid ICA 10 PED (1) 2 Patient on DAT because of previous PED 1 72 × 61 4
ASA, 325 mg; clopidogrel, 75 mg
4 F/70 HTN Saccular/R supraclinoid ICA 9 Coiled 1 Clopidogrel, 75 mg 6 70 × 49 6
Heparin IV
Progressive aspirin desensitization

Note:—L indicates left; R, right; ASA, acetylsalicylic acid; HTN, hypertension.

a

Size of the filling portion of the aneurysm as seen on angiography, measured in the single largest diameter.

b

Size measured as the largest oblique diameters on axial CT images.